Baicalein, an active component of Scutellaria baicalensis Georgi, prevents lysophosphatidylcholine-induced cardiac injury by reducing reactive oxygen species production, calcium overload and apoptosis via MAPK pathways

Baicalein protects against cardiac hypertrophy through blocking MEK-ERK1/2 signaling

(2012) Jing Zong et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Labedipinedilol-A prevents lysophosphatidylcholine-induced vascular smooth muscle cell death through reducing reactive oxygen species production and anti-apoptosis

(2011) Jong-Hau Hsu et al.   ATHEROSCLEROSIS

Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells

(2010) Kasey C. Vickers et al.   ATHEROSCLEROSIS

Intracellular Ca2+- and PKC-dependent upregulation of T-type Ca2+ channels in LPC-stimulated cardiomyocytes

(2009) Mingqi Zheng et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Luteolin Inhibits Lysophosphatidylcholine-Induced Apoptosis in Endothelial Cells by a Calcium/Mithocondrion/Caspases-Dependent Pathway

(2009) Junna Song et al.   PLANTA MEDICA

ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes

(2008) Jiahao Liu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling

(2008) G. W. Dorn   CARDIOVASCULAR RESEARCH

Baicalein protects chicken embryonic cardiomyocyte against hypoxia–reoxygenation injury via μ- and δ- but not κ-opioid receptor signaling

(2008) I-Hua Tu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-κB activity in vascular smooth-muscle cells

(2008) Chieh-Yu Peng et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Lercanidipine inhibits vascular smooth muscle cell proliferation and neointimal formation via reducing intracellular reactive oxygen species and inactivating Ras-ERK1/2 signaling

(2008) J WU et al.   PHARMACOLOGICAL RESEARCH